Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
Year: 2021
Type: article
Source: Leukemia
Authors: Patrick Harrington, Hugues de Lavallade, Katie J. Doores, Amy O’Reilly, Jeffrey Seow, Carl Graham, Thomas Lechmere, Deepti Radia, Richard Dillon, Yogita Shanmugharaj, Andreas Espehana, Claire Woodley, Jamie Saunders, Natalia Curto-Garcia, Jennifer O’Sullivan, Kavita Raj, Shahram Kordasti, Michael H. Malim, Claire N. Harrison, Donal P. McLornan
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: G127891921, G2347075150, G2363919153, G2647684415, Interferon and MX2 Mediated Control of HIV-1., Interferon and MX2 Mediated Control of HIV-1., DTP Bid Led by King's College London, G5861629431, G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation, G6122222817, G7063735130, Investigating COVID-19 infectiousness and antibody evolution in COVID-19 patients in SSA and Europe, G8229882807, G8415457339
OpenAlex ID: W3165718653